Clinical Trials - LXEO

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06109181Gene Therapy for ACM Due to a PKP2 Pathogenic VariantRECRUITINGPHASE1, PHASE22024-02-292027-022026-02
NCT05400330Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's DiseaseACTIVE_NOT_RECRUITINGPHASE12023-05-082028-112028-11
NCT05445323Gene Therapy for Cardiomyopathy Associated With Friedreich's AtaxiaACTIVE_NOT_RECRUITINGPHASE1, PHASE22022-08-242029-092029-09
NCT03634007Gene Therapy for APOE4 Homozygote of Alzheimer's DiseaseCOMPLETEDPHASE1, PHASE22019-11-062024-11-072024-11-07